| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Molecular Medicine |
From the Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, University of Oxford, United Kingdom.
Correspondence to Prof Roger Patient, Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, University of Oxford, Oxford OX3 9DS, United Kingdom. E-mail roger.patient{at}imm.ox.ac.uk
| Abstract |
|---|
|
|
|---|
Key Words: zebrafish gene duplication ETS transcription factors hemangioblast angiogenesis
| Introduction |
|---|
|
|
|---|
ETS domain genes encode a super family of transcription factors organized into 11 subfamilies based on domain structures, which are conserved from worm and fly to mammals.11 These transcription factors are involved in cell fate specification, proliferation, migration, and differentiation during embryonic development and adulthood and have been linked with diverse biological processes, from hematopoiesis, vasculogenesis, and angiogenesis to neurogenesis. Many important blood and endothelial regulators have well-conserved and functional ETS binding sites in their promoter and/or enhancer regions.12–15 For instance, the stem cell leukemia gene, Scl, a key regulator during hemangioblast formation and hematopoiesis, is regulated by a complex that consists of ETS transcription factors (Fli1 and Elf1) and other partners.12 Moreover, many ETS genes are coexpressed in hematopoietic and endothelial progenitor cells, which suggests they may have redundant roles or are synergistically required during hematopoiesis and vasculogenesis.11 Defects in human ETS counterpart genes, either by inappropriate expression or by fusions with other proteins, cause carcinogenesis, such as leukemia.16
To comprehensively explore the functional roles of ETS factors during hematopoiesis and vasculogenesis in zebrafish, we have used bioinformatics to systematically analyze the ETS family from the zebrafish genome (Table I in the online data supplement, available at http://circres.ahajournals.org). Interestingly, 12 of the 31 ETS genes identified showed expression in blood and endothelial precursors during embryonic development, which, together with phylogenetic analysis, suggested that some of them may have redundant or additive functions. Functional analysis of 3 of them, etsrp, erg and fli1, which are strongly expressed in blood and endothelial precursors/hemangioblasts, demonstrated that they are required for hemangioblast differentiation and angiogenesis.
| Materials and Methods |
|---|
|
|
|---|
Bioinformatics
To search for ETS genes, the sequences of the human and mouse ETS domains were used to TBLASTN the zebrafish genome in NCBI (http://www.ncbi.nlm.nih.gov). The predicted zebrafish ETS genes and proteins were named based on the alignment of their coding regions to known entries in public databases. To find the conserved domain in the protein sequences, NCBI conserved domain database was used (http://www.ncbi.nlm.nih.gov/Structure/cdd/wrpsb.cgi). To generate a phylogenetic tree, the full-length amino acid sequences of ETS proteins were aligned using the CLUSTALW program. Chromosome locations of ETS genes and their surrounding genes were obtained from the Ensembl zebrafish genome database as above.
Morpholinos
Antisense morpholinos (MOs) were obtained from GeneTools (Philomath, Ore). The MOs used in this work were erg atgMO (5'-AGTGACACTCACTCTCTCTGAGGTA-3'), erg spliceMO (5'-AGACGCCGTCATCTGCACGCTCAGA-3'), and flil utrMO (5'-TTTCCGCAATTTTCAGTGGAGCCCG-3'). etsrp atgMO was as reported previously.18 Stock solutions (1 mmol/L) in dH2O were prepared, and 2 to 10 ng amounts were injected into 1- to 2-cell stage embryos at the yolk/blastomere boundary. Both erg atgMO and spliceMO gave similar phenotype and coinjection of both MOs did not give a more severe phenotype than single injection.
Reverse Transcription–Polymerase Chain Reaction
RT-PCR analysis to determine efficacy of MO splicing inhibition was carried out with primers 5'-AGGCGCTGTCGGTGGTGAGTGAG-3' (erg forward) and 5'-TCTGCTGGCGTCTGGAGGGTAG-3' (erg reverse). cDNA template was produced from mRNA isolated from 24 hpf wild-type (wt) and erg spliceMO-injected embryos. PCR products were analyzed on 1% agarose gel.
Whole-Mount In Situ Hybridization
Whole mount in situ hybridization was performed as described.19 The following probes were used: fli1, scl, gata1, flk, pu.1,9,18 etsrp,18 pax2.1.20 erg, ets2, fev, elk4, gabpa, elf1, and elf2 were first reported in this work and their EST clones were obtained from ImaGenes (Berlin, Germany).
Photography
Images of live embryos were captured using a Nikon SMZ 1500 dissecting microscope (x1 HR Plan Apo objective; numeric aperture, 0.13) with a Nikon DXM1200 digital camera driven by Nikon Act-1 version 2.12 software (Nikon). Confocal images were acquired with a Zeiss LSM 510 META confocal laser microscope and 3D projections were generated using Zeiss LSM software (Carl Zeiss Inc).
| Results |
|---|
|
|
|---|
Phylogenetic analysis with the complete open reading frames of the ETS transcription factors, identified 11 subfamilies within the ETS gene family (supplemental Table I and Figure 1), which is consistent with the classification of mammalian counterparts based on their structural composition and their similarities in the DNA-binding ETS domains. Besides the conserved ETS domain, a subset of ETS family proteins has another evolutionarily conserved domain called the POINTED (PNT) domain at their N-terminal regions, which is required for protein–protein interactions. Notably, because of genome duplication, there are several genes that are closely related in this family (supplemental Table I). For example, there are 3 erf-like genes, erfl1, erfl2, and erfl3, similar to erf itself, which are the orthologs of the mammalian erf gene. There are another 3 pairs of ETS genes, ie, elk4 and elk4l1, elf2 and elf2l1, spic and spicl1, which show high homology to a single mammalian gene.
|
Developmental Expression Patterns of Twelve Hematopoietic or Endothelial ETS Genes
To systemically characterize expression of these ETS genes in wt embryos, we performed a detailed expression pattern analysis at various developmental stages (Figure 2, supplemental Figure I, and data not shown). We obtained cDNA clones for 27 of the 31 ETS genes (the other 4 clones are duplicate genes, ie, erfl2, elk4l1, elf2, and spicl1, which should give similar expression patterns because of high similarity of the sequences) (supplemental Table I) and subjected zebrafish embryos to in situ hybridization at 1-somite (1s), 6s, 10s, and 26-hpf stages when hemangioblasts and erythroid/myeloid and endothelial lineages are clearly identifiable (Figure 2, supplemental Figure I, and data not shown). Compared to the known hemangioblast marker, scl (supplemental Figure I, A through D), we found that 12 ETS genes are expressed in the right place and early enough to be involved in hemangioblast formation (Figure 2 and supplemental Figure I). These are ets1, ets2, etsrp, fli1, fli1b, erg, fev, gabpa, elf1, elf2, pu.1, and elk4. Importantly, among them, ets2, erg, fev, gabpa, elf1, elf2, and elk4 are reported for the first time in this study. Of note, etsrp is the earliest ETS gene strongly expressed in the anterior lateral plate mesoderm (ALM) (Figure 2A), which will give rise to myeloid and endothelial cells in zebrafish. In the posterior lateral plate mesoderm (PLM), fli1 is the earliest and strongest expressed at 1s among these 12 genes (Figure 2E). erg is also expressed in the PLM at the 1s stage (Figure 2M). Later on, all of them except pu.1 are expressed in endothelial cells at 26 hpf (Figure 2 and supplemental Figure I), suggesting that they might play roles in angiogenesis.
|
Expression Analysis in clo Mutants Confirms That Twelve ETS Genes Are Specifically Expressed in Hematopoietic or Endothelial Cells
To confirm the expression of the 12 ETS genes in hematopoietic and endothelial cells, we tested whether their expression was affected in clo mutants, which lack both blood and endothelial cells. So far, clo mutants exhibit the earliest hematopoietic and endothelial lineage defects in zebrafish.7 As shown in Figure 3 and supplemental Figure II, endothelial expression of 11 ETS genes, ie, ets1, ets2, etsrp, fli1, fli1b, erg, fev, gabpa, elf1, elf2, and elk4, and myeloid expression of pu.1 were reduced or absent in clo embryos at 26 hpf, suggesting that they are indeed expressed in hematopoietic or endothelial cells. Of note, neural crest expression of fli1, ets1, gabpa, elf1, and elf2 were relatively normal in clo embryos (Figure 3B and supplemental Figure II, A, D, E, and F), compared to wt siblings.
|
etsrp Is Required for Anterior Hemangioblast (Endothelial/Myeloid Progenitor) Differentiation
Gene expression profiling showed that fli1, erg, and etsrp are strongly expressed in the putative hemangioblast population in 10s stage embryos and later on are restricted to endothelial cells (Figure 2). We reasoned that they might be involved in blood/endothelial progenitor specification and differentiation, as well as in angiogenesis. erg has previously been implicated in angiogenesis and in some leukemia cases in mammalian cell lines.21 Because no knockout mice for erg had been reported (but see Discussion), we decided to use the zebrafish as a model to study the function of erg in vivo. To knockdown erg expression in zebrafish, we designed 2 antisense MOs (Figure 4A). The erg atgMO was designed to target the erg ATG and inhibit translation. The erg spliceMO was directed against the boundary of exon 4 and intron 4, spanning part of the PNT domain, to skip exon 4 and generate a truncated protein containing only a small portion of the PNT domain and, because of a frameshift, no downstream ETS DNA binding domain (Figure 4A). To test MO efficiency, RT-PCR analysis of erg spliceMO-injected embryos was carried out, revealing the formation of aberrantly spliced RNAs (Figure 4B, lower arrow in spliceMO-injected embryos), instead of the wt product, which was virtually abolished (Figure 4B, upper arrow in control embryos). Thus, endogenous erg activity was substantially knocked down with the splice MO. spliceMO-injected embryos developed normally without any obvious morphological defects, apart from a hemorrhage in the head area between 2.5 and 3 days postfertilization (see below). The atgMO gave a similar hemorrhage phenotype (data not shown), indicating that the hemorrhage is a specific phenotype caused by erg knockdown.
|
To determine the consequences of loss-of-function of fli1, we designed an antisense MO against the 5' untranslated region immediately upstream of the fli1 translation initiation codon. This fli1 utrMO completely abolished the green fluorescent protein (GFP) expression in fli1:gfp embryos, suggesting that this antisense MO knockdown strategy was efficient (Figure 4D). The fli1 morphants also developed a hemorrhage in the head around 2.5 days postfertilization (supplemental Figure IV).
etsrp has been demonstrated to be involved in endothelial differentiation but is dispensable for erythroid development in zebrafish embryos.18 However, its role in the earliest precursor, the hemangioblast, has not yet been tested. Knockdown experiments showed that whereas fli1MO and ergMO had no effects on the early hemangioblast program in both ALM and PLM, etsrpMO caused significant reduction of scl and an absence of pu.1 and flk1 expression in the ALM, which gives rise to myeloid and endothelial lineages in wt embryos (supplemental Figure III). In contrast, the erythroid marker gata1 was not affected in the PLM of all 3 morphants (supplemental Figure III, U through X).
To confirm the etsrpMO phenotype, we used the available etsrp mutant, y11, in zebrafish.22 The predicted Etsrp polypeptides synthesized in the homozygous mutant contain only a quarter of the wt Etsrp protein and do not have the well-conserved ETS DNA binding domain essential for the function of ETS genes. Therefore, it is very likely to be a null allele, which should phenocopy the loss-of-function phenotype induced by etsrp atgMO injection. Whole-mount in situ hybridization shows that the hemangioblast marker, scl, was significantly reduced or absent in the ALM of y11 embryos (Figure 5A). The myeloid marker pu.1 was completely absent, and the endothelial marker flk1 was also absent in both the ALM and the PLM (Figure 5B, 5C, and 5E). In the PLM, scl expression was downregulated in y11 embryos (Figure 5D), suggesting that etsrp is also involved in posterior hemangioblast differentiation into the endothelial lineage. The erythroid marker gatal was not affected at either the 10s stage in the PLM (Figure 5F) or at 24 hpf in the intermediate cell mass (data not shown), confirming that etsrp is not required for erythroid differentiation.18
|
Knockdown of erg and fli1 Causes Angiogenesis Defects and Downregulation of VE-Cadherin
To further characterize the erg morphant phenotype, we injected ergMOs into flk1:gfp-gata1:dsRed transgenic embryos to visualize the whole vasculature and blood circulation. The hemorrhage phenotype was reproduced in
40% of injected embryos. Confocal microscopy clearly showed that the hemorrhage occurred in the head vasculature from 60 hpf onward in erg spliceMO-injected embryos (Figure 6A through 6F, arrows). In addition, we also found that intersomitic vessel (ISV) patterning was slightly affected (Figure 6H). In the controls, ISVs were arranged in very regular chevron shapes (Figure 6G). However, in the erg morphants, ISVs often did not follow this chevron shape and grew either straight or reversely (Figure 6H).
|
Fli1 and Erg belong to the same subfamily in the ETS family (supplemental Table I and Figure 1), and interestingly fli1 and erg MOs gave similar hemorrhage phenotypes in the head at around 60 to 72 hpf (supplemental Figure IV, A through C). Moreover, fli1 knockout mice also showed a hemorrhage phenotype in the head.23,24 These data suggest that erg and fli1 are involved in establishing and/or maintaining vessel integrity. Because the 2 genes have similar expression patterns in mice and also in zebrafish, these 2 ETS transcription factors could either be equally or redundantly required for angiogenesis and vessel remodeling after the endothelial cells have been specified (vasculogenesis). However, double knockdown of both fli1 and erg gave a more severe phenotype than the individual knockdowns, namely a more severe ISV patterning defect and higher penetrance of the hemorrhage (71% versus 41%, Figure 6I versus 6H and data not shown). In the double knockdown, ISVs were more disorganized and they did not grow properly toward the dorsal side of the embryo (Figure 6I, arrows). In addition, the dorsal longitudinal anastomotic vessel did not develop properly in the double knockdown morphants (Figure 6I, dotted box), which contrasts with the individual knockdowns (Figure 6H, dotted box). Thus, these data demonstrate that erg and fli1 are additively required for vessel integrity and angiogenic remodeling.
VE-cadherin, a key regulator of endothelial intercellular junctions, has recently been shown, by chromatin immunoprecipitation and functional assays, to be a direct target of erg in human umbilical vein endothelial cells.25 We, therefore, looked at VE-cadherin mRNA expression in the erg, fli1, and double morphants. At 24 hpf, VE-cadherin was equally expressed in both controls and the morphants (data not shown). However, there was a reduction of VE-cadherin expression in both the trunk and the head at 50 hpf in the morphants (supplemental Figure IV, D through G, arrows), just before the hemorrhage occurred, suggesting that downregulation of VE-cadherin by erg and fli1 knockdown might be responsible for the hemorrhage and ISV patterning defects observed in the morphants.
| Discussion |
|---|
|
|
|---|
The ETS Family and Genome Duplication
Our phylogenetic tree analysis indicates that the zebrafish genome contains 3 pairs of duplicated ETS genes, ie, elk4 and elk4l1, elf2 and elf2l1, spic and spicl1, and 1, erf, that has 3 diverged copies (supplemental Table I and Figure 1). The zebrafish-specific ETS gene duplicates may result from zebrafish-specific gene duplication or mammalian-specific gene loss, or both. Several lines of evidence suggest that whole-genome duplication and subsequent massive loss of duplicated genes occurred in the teleost.26–29 Syntenic analysis further confirmed the likelihood of a genome-wide duplication. For example, the ets1-fli1 pair on chromosome 18 has been duplicated and their duplicates, etsrp and fli1b are located on chromosome 16. In the most extreme case, erf has 3 additional duplicates. These duplicated ETS genes, together with their surrounding genes, often form duplicated chromosome segments located on either the same chromosome or a different chromosome, further suggesting genome duplication occurred. Of note, their close neighboring genes also have putative mammalian orthologs located near the human counterpart genes, highlighting highly conserved syntenies between zebrafish and mammals such as human and mouse. Taken together, our data and published data strongly support the view that the zebrafish-specific ETS genes arose from genome-wide duplication.26–29
A Role for Etsrp in Hemangioblast Formation
The list of genes involved in both blood and endothelial lineages is expanding, although the existence of a bipotential progenitor, the hemangioblast, is still contentious. Scl, Lmo2 and Gata2 have all been demonstrated to be critical for the hemangioblast program.8,9,20,30–32 Using binding and transactivation assays, Pimanda et al have implicated Fli1 in the control of scl and gata2 expression; however, no perturbations were performed to support such a role in hemangioblasts.32 We show here that, although erg and fli1 are expressed in the hemangioblast population, loss of their functions in zebrafish has no effect on hemangioblast development, suggesting that they are either not required or possibly redundantly required. We have recently found that fli1 is indeed essential for blood and endothelial development in Xenopus embryos and that gain-of-function of fli1 can induce many hemangioblast markers in zebrafish, consistent with a role for this family at the top of gene regulatory hierarchy.33 However, even a quadruple knockdown of erg, fli1, fli1b, and fev (belonging to the same subfamily) did not give a hemangioblast phenotype (supplemental Figure V), indicating that if redundancy is the explanation, it involves ETS factors outside this subfamily in zebrafish.
Etsrp, an ETS domain protein discovered in zebrafish, has been shown to be necessary and sufficient for the initiation of vasculogenesis.18 Here, we have clearly demonstrated, by using antisense MO knockdown and a genetic homozygous mutant, that Etsrp is absolutely required for anterior hemangioblast formation in zebrafish. This requirement could be cell-autonomous, because etsrp is coexpressed with scl and flk1 in the same cell population, the anterior lateral plate mesoderm, during embryogenesis. As etsrp is dispensable for erythroid differentiation, it suggests that the anterior hemangioblast, only giving rise to myeloid and endothelial lineages, and the posterior hemangioblast population, giving rise to erythroid and endothelial lineages, are differentially programmed. It is highly possible that both cell-intrinsic differences and local environments account for the differential regulation of these 2 hemangioblast populations. Our studies have identified etsrp as a critical regulator required for generation of the hemangioblasts that differentiate into myeloid and endothelial lineages. Consistent with our finding, mice carrying a mutation in Er71, the homolog of etsrp in mammals, have very recently been shown to lack both hematopoietic and endothelial lineages.34
Sumanas et al recently reported the dependence of myeloid gene expression on etsrp in the anterior hemangioblast population in zebrafish embryos.35 They showed, by etsrpMO knockdown that myeloid markers, such as lcp1, mpx, and pu.1, were reduced and that overexpression of etsrp could upregulate lcp1 and pu.1 expression. However, anterior expression of endothelial markers, such as flk1, was not analyzed. Together with our data, we can conclude that etsrp lies at the top of the genetic hierarchy programming both blood and endothelium in the anterior hemangioblast population. A recent study by Xiong et al36 showing that etsrp can partially rescue both hematopoietic and endothelial defects in cloche embryos is consistent with our finding here.
Erg, Fli1, and Angiogenesis
Although erg is dispensable for the hemangioblast program, its specific expression in endothelial cells at later stages of development suggests that it might be involved in angiogenesis. In addition, fli1 knockout mice showed a central nervous system hemorrhage phenotype, suggesting that it is not redundant in angiogenesis.23,24 In contrast, the very recently reported ErgMld mutation did not cause a vasculature phenotype in mice.37 A possible explanation is that this Mld2 mutation, which caused a substitution in the ETS DNA-binding domain but did not affect DNA binding affinity, might not therefore be a null allele. Many ETS genes have been implicated in angiogenesis.11 Pham et al have demonstrated a combinatorial function for ETS transcription factors, fli1, fli1b, ets1, and etsrp, in the developing vasculature in the zebrafish.22 The additive interaction of erg and fli1 discovered in this study supports such combinatorial functions among ETS factors in vessel development.
Downregulation of VE-cadherin, a key molecule involved in cell–cell junctions and cell survival, by erg and fli1 knockdown could explain why a hemorrhage occurred in both morphants. Targeted null mutation of VE-cadherin impairs the organization of vascular-like structures in embryoid bodies.39 More importantly, electrophoretic mobility shift assays and chromatin immunoprecipitation analyses showed that Erg binds to the VE-cadherin promoter.25,40 The strongest expression of VE-cadherin and erg/fli1 in the head vasculature indicates that they might be particularly essential for the vessel integrity and stabilities in that region. However, we have not been able to detect any discernible defects in the head vasculature, even using confocal microscopy imaging of the flk1:GFP/gata1:dsRed double transgenic line, although the hemorrhage always occurs in the head. The hemorrhage phenotype in the erg morphants is very similar to the hemorrhaged mutants recently identified in zebrafish, such as bubblehead/βpix and redhead/pak2a.41,42 It was suggested that βPix-Pak2a signaling pathways regulate cerebral vascular stability, possibly via the p38 mitogen-activated protein kinase pathway.41 Nevertheless, it would be intriguing to know whether expression of VE-cadherin was affected in these mutants, as in the erg and fli1 morphants described here. As a first test for effects on FGF or VEGF signaling, 2 pathways known to be important in angiogenesis, we asked whether activated forms of Erg or Fli1 could induce expression of the ligands (supplemental Figure VI, D through I). However, we found that vegf expression was unaffected and, even though fgf8 expression was upregulated, it was in the tail bud and not the vasculature. In contrast, both activated ETS factors, upregulated flk1 expression (supplemental Figure VI, A through C), raising the possibility that they might sensitize endothelial cells to VEGF signaling.
In conclusion, by using systematic bioinformatic analysis and gene expression profiling, we have comprehensively characterized the whole ETS gene family in zebrafish and identified 12 of the 31 ETS genes as expressing in hematopoietic or endothelial tissues. Functional assays have identified 3 genes, etsrp, erg, and fli1, that are specifically required for hemangioblast development and angiogenesis. Our studies provide new insights into how tissue-specific differentiation and maintenance is achieved by the ETS domain transcription factors during hematopoiesis, vasculogenesis, and angiogenesis.
| Acknowledgments |
|---|
Sources of Funding
This work was funded by the Medical Research Council (United Kingdom).
Disclosures
None.
| Footnotes |
|---|
| References |
|---|
|
|
|---|
2. Keller G. The Hemangioblast. In: Marshak DR, Gardner RL, Gottlieb D, eds. Stem Cell Biology. New York: Cold Spring Harbor Laboratory Press; 2001: 329–348.
3. Sabin FR. Studies on the origins of blood-vessels and of red blood-corpuscles as seen in the living blastoderm of chicks during the second day of development. Contrib Embryol. 1920; 36: 213–262.
4. Shalaby F, Rossant J, Yamaguchi TP, Gertenstein M, Wu XF, Breitman ML, Schuh AC. Failure of blood-island formation and vasculogenesis in Flk-1 deficient mice. Nature. 1995; 376: 62–66.[CrossRef][Medline] [Order article via Infotrieve]
5. Ferrara N, Carver-Moore K, Chen H, Dowd M, Lu L, O'Shea KS, Powell-Braxton L, Hillan KJ, Moore MW. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature. 1996; 380: 439–442.[CrossRef][Medline] [Order article via Infotrieve]
6. Carmeliet P, Ferreira V, Breier G, Pollefeyt S, Kieckens L, Gertsenstein M, Fahrig M, Vandenhoeck A, Harpal K, Eberhardt C, Declercq C, Pawling J, Moons L, Collen D, Risau W, Nagy A. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature. 1996; 380: 435–439.[CrossRef][Medline] [Order article via Infotrieve]
7. Stainier DY, Weinstein BM, Detrich HW III, Zon LI, Fishman MC. Cloche, an early acting zebrafish gene, is required by both the endothelial and hematopoietic lineages. Development. 1995; 121: 3141–3150.[Abstract]
8. Patterson LJ, Gering M, Eckfeldt CE, Green AR, Verfaillie CM, Ekker SC, Patient R. The transcription factors Scl and Lmo2 act together during development of the hemangioblast in zebrafish. Blood. 2007; 109: 2389–2398.
9. Patterson LJ, Gering M, Patient R. Scl is required for dorsal aorta as well as blood formation in zebrafish embryos. Blood. 2005; 105: 3502–3511.
10. Dooley KA, Davidson AJ, Zon LI. Zebrafish scl functions independently in hematopoietic and endothelial development. Dev Biol. 2005; 277: 522–536.[CrossRef][Medline] [Order article via Infotrieve]
11. Oikawa T, Yamada T. Molecular biology of the Ets family of transcription factors. Gene. 2003; 303: 11–34.[CrossRef][Medline] [Order article via Infotrieve]
12. Gottgens B, Nastos A, Kinston S, Piltz S, Delabesse EC, Stanley M, Sanchez MJ, Ciau-Uitz A, Patient R, Green AR. Establishing the transcriptional programme for blood: the SCL stem cell enhancer is regulated by a multiprotein complex containing Ets and GATA factors. Embo J. 2002; 21: 3039–3050.[CrossRef][Medline] [Order article via Infotrieve]
13. Chan WY, Follows GA, Lacaud G, Pimanda JE, Landry JR, Kinston S, Knezevic K, Piltz S, Donaldson IJ, Gambardella L, Sablitzky F, Green AR, Kouskoff V, Gottgens B. The paralogous hematopoietic regulators Lyl1 and Scl are coregulated by Ets and GATA factors, but Lyl1 cannot rescue the early Scl-/- phenotype. Blood. 2007; 109: 1908–1916.
14. Pimanda JE, Silberstein L, Dominici M, Dekel B, Bowen M, Oldham S, Kallianpur A, Brandt SJ, Tannahill D, Gottgens B, Green AR. Transcriptional link between blood and bone: the stem cell leukemia gene and its +19 stem cell enhancer are active in bone cells. Mol Cell Biol. 2006; 26: 2615–2625.
15. Landry JR, Kinston S, Knezevic K, Donaldson IJ, Green AR, Gottgens B. Fli1, Elf1, and Ets1 regulate the proximal promoter of the LMO2 gene in endothelial cells. Blood. 2005; 106: 2680–2687.
16. Sharrocks AD. The ETS-domain transcription factor family. Nat Rev Mol Cell Biol. 2001; 2: 827–837.[CrossRef][Medline] [Order article via Infotrieve]
17. Westerfield M. The Zebrafish Book: A Guide for the Laboratory Use of Zebrafish (Brachydanio rerio). Eugene, Ore: University of Oregon Press; 1993.
18. Sumanas S, Lin S. Ets1-related protein is a key regulator of vasculogenesis in zebrafish. PLoS Biol. 2006; 4: e10.[CrossRef][Medline] [Order article via Infotrieve]
19. Jowett T, Yan YL. Double fluorescent in situ hybridization to zebrafish embryos. Trends Genet. 1996; 12: 387–389.[CrossRef][Medline] [Order article via Infotrieve]
20. Gering M, Yamada Y, Rabbitts TH, Patient RK. Lmo2 and Scl/Tal1 convert non-axial mesoderm into haemangioblasts which differentiate into endothelial cells in the absence of Gata1. Development. 2003; 130: 6187–6199.
21. Sato Y. Role of ETS family transcription factors in vascular development and angiogenesis. Cell Struct Funct. 2001; 26: 19–24.[CrossRef][Medline] [Order article via Infotrieve]
22. Pham VN, Lawson ND, Mugford JW, Dye L, Castranova D, Lo B, Weinstein BM. Combinatorial function of ETS transcription factors in the developing vasculature. Dev Biol. 2007; 303: 772–783.[CrossRef][Medline] [Order article via Infotrieve]
23. Hart A, Melet F, Grossfeld P, Chien K, Jones C, Tunnacliffe A, Favier R, Bernstein A. Fli-1 is required for murine vascular and megakaryocytic development and is hemizygously deleted in patients with thrombocytopenia. Immunity. 2000; 13: 167–177.[CrossRef][Medline] [Order article via Infotrieve]
24. Spyropoulos DD, Pharr PN, Lavenburg KR, Jackers P, Papas TS, Ogawa M, Watson DK. Hemorrhage, impaired hematopoiesis, and lethality in mouse embryos carrying a targeted disruption of the Fli1 transcription factor. Mol Cell Biol. 2000; 20: 5643–5652.
25. Birdsey GM, Dryden NH, Amsellem V, Gebhardt F, Sahnan K, Haskard DO, Dejana E, Mason JC, Randi AM. Transcription factor Erg regulates angiogenesis and endothelial apoptosis through VE-cadherin. Blood. 2008; 111: 3498–3506.
26. Woods IG, Wilson C, Friedlander B, Chang P, Reyes DK, Nix R, Kelly PD, Chu F, Postlethwait JH, Talbot WS. The zebrafish gene map defines ancestral vertebrate chromosomes. Genome Res. 2005; 15: 1307–1314.
27. Postlethwait JH, Yan YL, Gates MA, Horne S, Amores A, Brownlie A, Donovan A, Egan ES, Force A, Gong Z, Goutel C, Fritz A, Kelsh R, Knapik E, Liao E, Paw B, Ransom D, Singer A, Thomson M, Abduljabbar TS, Yelick P, Beier D, Joly JS, Larhammar D, Rosa F, Westerfield M, Zon LI, Johnson SL, Talbot WS. Vertebrate genome evolution and the zebrafish gene map. Nature Genet. 1998; 18: 345–349.[CrossRef][Medline] [Order article via Infotrieve]
28. Amores A, Force A, Yan YL, Joly L, Amemiya C, Fritz A, Ho RK, Langeland J, Prince V, Wang YL, Westerfield M, Ekker M, Postlethwait JH. Zebrafish hox clusters and vertebrate genome evolution. Science. 1998; 282: 1711–1714.
29. Sun XJ, Xu PF, Zhou T, Hu M, Fu CT, Zhang Y, Jin Y, Chen Y, Chen SJ, Huang QH, Liu TX, Chen Z. Genome-wide survey and developmental expression mapping of zebrafish SET domain-containing genes. PLoS ONE. 2008; 3: e1499.[CrossRef][Medline] [Order article via Infotrieve]
30. Gering M, Rodaway AR, Gottgens B, Patient RK, Green AR. The SCL gene specifies haemangioblast development from early mesoderm. EMBO J. 1998; 17: 4029–4045.[CrossRef][Medline] [Order article via Infotrieve]
31. Lugus JJ, Chung YS, Mills JC, Kim SI, Grass J, Kyba M, Doherty JM, Bresnick EH, Choi K. GATA2 functions at multiple steps in hemangioblast development and differentiation. Development. 2007; 134: 393–405.
32. Pimanda JE, Ottersbach K, Knezevic K, Kinston S, Chan WY, Wilson NK, Landry JR, Wood AD, Kolb-Kokocinski A, Green AR, Tannahill D, Lacaud G, Kouskoff V, Gottgens B. Gata2, Fli1, and Scl form a recursively wired gene-regulatory circuit during early hematopoietic development. Proc Natl Acad Sci U S A. 2007; 104: 17692–17697.
33. Liu F, Walmsley M, Rodaway A, Patient R. Fli1 acts at the top of the transcriptional network driving blood and endothelial development. Curr Biol. 2008; 18: 1234–1240.[CrossRef][Medline] [Order article via Infotrieve]
34. Lee D, Park C, Lee H, Lugus JJ, Kim SH, Arentson E, Chung YS, Gomez G, Kyba M, Lin S, Janknecht R, Lim DS, Choi K. ER71 acts downstream of BMP, Notch, and Wnt signaling in blood and vessel progenitor specification. Cell Stem Cell. 2008; 2: 497–507.[CrossRef][Medline] [Order article via Infotrieve]
35. Sumanas S, Gomez G, Zhao Y, Park C, Choi K, Lin S. Interplay among Etsrp/ER71, Scl, and Alk8 signaling controls endothelial and myeloid cell formation. Blood. 2008; 111: 4500–4510.
36. Xiong JW, Yu Q, Zhang J, Mably JD. An acyltransferase controls the generation of hematopoietic and endothelial lineages in zebrafish. Circ Res. 2008; 102: 1057–1064.
37. Loughran SJ, Kruse EA, Hacking DF, de Graaf CA, Hyland CD, Willson TA, Henley KJ, Ellis S, Voss AK, Metcalf D, Hilton DJ, Alexander WS, Kile BT. The transcription factor Erg is essential for definitive hematopoiesis and the function of adult hematopoietic stem cells. Nat Immunol. 2008; 9: 810–819.[CrossRef][Medline] [Order article via Infotrieve]
38. Carrere S, Verger A, Flourens A, Stehelin D, Duterque-Coquillaud M. Erg proteins, transcription factors of the Ets family, form homo, heterodimers and ternary complexes via two distinct domains. Oncogene. 1998; 16: 3261–3268.[CrossRef][Medline] [Order article via Infotrieve]
39. Vittet D, Buchou T, Schweitzer A, Dejana E, Huber P. Targeted null-mutation in the vascular endothelial-cadherin gene impairs the organization of vascular-like structures in embryoid bodies. Proc Natl Acad Sci U S A. 1997; 94: 6273–6278.
40. Gory S, Dalmon J, Prandini MH, Kortulewski T, de Launoit Y, Huber P. Requirement of a GT box (Sp1 site) and two Ets binding sites for vascular endothelial cadherin gene transcription. J Biol Chem. 1998; 273: 6750–6755.
41. Buchner DA, Su F, Yamaoka JS, Kamei M, Shavit JA, Barthel LK, McGee B, Amigo JD, Kim S, Hanosh AW, Jagadeeswaran P, Goldman D, Lawson ND, Raymond PA, Weinstein BM, Ginsburg D, Lyons SE. pak2a mutations cause cerebral hemorrhage in redhead zebrafish. Proc Natl Acad Sci U S A. 2007; 104: 13996–14001.
42. Liu J, Fraser SD, Faloon PW, Rollins EL, Vom Berg J, Starovic-Subota O, Laliberte AL, Chen JN, Serluca FC, Childs SJ. A betaPix Pak2a signaling pathway regulates cerebral vascular stability in zebrafish. Proc Natl Acad Sci U S A. 2007; 104: 13990–13995.
Related Article:
Circ. Res. 2008 103: 1050-1052.
This article has been cited by other articles:
![]() |
T. Peterkin, A. Gibson, and R. Patient Common genetic control of haemangioblast and cardiac development in zebrafish Development, May 1, 2009; 136(9): 1465 - 1474. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Ruel, A. F.R. Stewart, and E. J. Suuronen From Genes to Regenerative Medicine: Approaches in Development Circ. Res., November 7, 2008; 103(10): 1050 - 1052. [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Circulation Research Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2008 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |